The Quiet Consolidation Happening Across Therapy Clinics
Small occupational therapy practices built over decades by solo clinicians or husband-and-wife teams are disappearing from the independent market at a pace most patients never notice. The storefronts stay the same, the staff often remains, and the logo might not change for months – but the ownership structure underneath has been quietly transferred to a private equity-backed platform company executing a regional or national rollup strategy.
This consolidation has been building for years in physical therapy, where PE rollups reshaped entire markets before most practitioners understood what was happening. Occupational therapy is now following the same arc, and the deals are accelerating as platform companies compete to lock up geography before rivals do.
Why OT Clinics Became a Target
Occupational therapy practices carry a specific financial profile that makes them attractive to rollup buyers. They generate steady, recurring revenue tied to insurance reimbursement schedules, they operate with relatively low capital overhead compared to surgical or imaging facilities, and they tend to hold strong referral relationships with hospitals, schools, and physicians that took years to build. A clinic treating pediatric sensory processing disorders or post-stroke patients is not just selling a service – it is selling a pipeline that a buyer can immediately monetize and expand through volume.
The reimbursement model also matters. Occupational therapy is covered under Medicare, Medicaid, and most commercial insurance plans, which means revenue is relatively predictable. PE buyers prize predictability because it supports the debt financing that funds acquisition activity. A clinic billing consistently at 80 to 90 percent capacity, with a waitlist, looks like exactly the kind of asset a platform company wants to bolt onto its existing network before negotiating better payer contracts across the combined entity.
How the Deal Process Actually Works
Most clinic owners who sell to a rollup did not go looking for a buyer. They were approached – often by a business development associate working for a PE-backed platform that has already acquired several practices in the same region. The initial conversation rarely leads with acquisition. It starts with a question about growth challenges, staffing shortages, or administrative burden. By the time a letter of intent appears, the owner has already spent months building a relationship with the acquiring team.
The valuation multiples being offered have risen as competition between platforms intensified. A well-run OT practice with strong documentation, a clean payer mix, and retained therapists can attract offers based on a multiple of EBITDA – earnings before interest, taxes, depreciation, and amortization – that would have seemed improbable five years ago. This is partly a function of low interest rates during the period when many of these platforms were capitalized, and partly a function of the rollup logic itself: the platform is not just buying one clinic’s earnings, it is buying market position.
Sellers frequently retain a minority equity stake in the acquiring platform as part of the deal structure. This is sometimes framed as a partnership, and in the short term it often feels like one. The original owner may stay on as a clinical director, the staff receives pay continuity, and day-to-day operations look unchanged. The friction tends to appear later, when the platform pushes for productivity benchmarks, documentation software standardization, or headcount decisions that a solo owner would have made differently.
That tension is not incidental – it is structural. The PE model requires the platform to grow its EBITDA before a sale or recapitalization event, typically within a three-to-seven-year fund cycle. That pressure flows downward to each acquired clinic. This is broadly similar to what happened when regional radiology reading groups began selling to larger networks, where operational standardization followed acquisition almost immediately.
What Consolidation Does to Care and Staffing
From a patient perspective, the most immediate change is often scheduling. Platform companies typically invest in centralized intake systems and scheduling software designed to reduce no-show rates and increase throughput per therapist per day. That can mean shorter appointment slots, less flexibility for complex cases, and a shift away from the relationship-driven scheduling that smaller clinics offered. Patients who were used to seeing the same therapist weekly may find that consistency harder to maintain as productivity targets shift session volume.
For occupational therapists themselves, the rollup environment is a mixed reality. Entry-level salaries at platform-owned clinics have, in some markets, risen as platforms compete to attract and retain licensed therapists in a tight labor market. But experienced clinicians who joined independent practices specifically to avoid corporate environments often find the cultural shift significant. Caseload expectations rise, administrative requirements increase, and clinical autonomy narrows when standardized protocols replace individualized treatment planning.
The Geography of Acquisition
Platform companies are not acquiring randomly. They target markets where population density supports volume, where existing OT coverage is fragmented enough to leave consolidation room, and where the competitive set has not yet been locked up by a rival platform. Secondary cities and suburban corridors with aging populations or growing pediatric demand have seen particular activity, because they offer the referral base without the acquisition cost premium of major metro markets.
Once a platform establishes two or three clinics in a region, the strategy often shifts to dominance – acquiring enough of the referral relationships that hospital systems and school districts default to the platform’s network. At that point, independent clinics in the same geography face a harder competitive environment even if they chose not to sell. Their referral sources may be redirected by systems that have formal contracts with the larger network, and their ability to recruit therapists competes against a platform that can offer benefits packages a solo practice cannot match.
Where the Money Ultimately Goes
Private equity’s interest in occupational therapy is not a long-term ownership play. The fund model is designed around an exit, typically a sale to a larger strategic buyer, a public listing, or a secondary buyout by another PE firm at a higher valuation. Every acquisition the platform makes is meant to increase the size and defensibility of the enterprise before that exit. The clinic owner who sold for what felt like a fair multiple is, in that framework, a building block in a larger financial structure.
The downstream buyer at exit is often a national health system, an insurance company with care delivery ambitions, or another private equity firm operating a larger fund. At each transaction, the original therapeutic mission of the clinic travels further from the decision-making center. Whether that produces better or worse outcomes for patients depends largely on how much clinical autonomy survives the successive ownership transitions.
The clinics most likely to resist this pressure are those with waiting lists long enough that they do not need external referrals, practices specializing in areas where standardization is genuinely difficult, and owners who structured their practices from the start to operate without the administrative simplification that makes acquisition attractive to buyers. For everyone else, the question is not whether a PE platform will call – it is when.
